EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cerebrospinal fluid haptoglobin levels and outcome after aneurysmal subarachnoid haemorrhage: Evidence from Mendelian randomization

Gbenga A Kayode, Loukas Zagkos iD, Godspower Oboli, Sonya Abraham, Gregory Kato iD, Quazi Ataher, Evangelia Farmakioti, Lothar Tremmel, Stephen Burgess

PLOS One · 2025

DOI: 10.1371/journal.pone.0329287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Gbenga A Kayode und 8 weiteren Autor:innen. Beteiligte Einrichtung: CSL BEHRING L.L.C., King of Prussia, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Haptoglobins, Subarachnoid Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSL Behring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Subarachnoid haemorrhage (SAH) poses a life-threatening risk, contributing to half of all haemorrhagic strokes, with aneurysmal SAH (aSAH) affecting approximately 6 individuals per 100,000 annually. Following aSAH, the influx of plasma haptoglobin into the cerebrospinal fluid (CSF) is insufficient to sequester the released free haemoglobin in the subarachnoid space and avoid its neurotoxic effects. Exogenous administration of haptoglobin could be a therapeutic strategy for improving outcomes after aSAH.

Methods

Using individual level data in the UK Biobank and genetic summary statistics from the largest relevant cohorts, Mendelian randomization analysis was conducted to explore the associations of genetically predicted CSF haptoglobin with the risk of catastrophic aSAH (i.e., fatal aSAH or non-fatal aSAH with at least one of: hemiparesis, aphasia, apraxia, or visual field defects within 7 days) and secondary traits, including stroke-related outcomes and imaging markers of brain swelling.

Results

Higher levels of genetically predicted CSF haptoglobin was associated with lower risk of catastrophic aSAH in multi-ancestry (OR: 0.79, 95% CI: 0.65 to 0.96, p = 0.019) and White British sample analyses (OR: 0.78, 95% CI: 0.63 to 0.95, p = 0.013), while the lack of association with related traits supported effects specific to outcomes after aSAH. A proof-of-concept analysis showing associations of genetically predicted haptoglobin with haemoglobin in plasma validated the proposed mechanism.

Conclusions

Using human genetic data, we provide evidence to support a causal role of higher CSF haptoglobin in improving outcomes after aSAH. However, there was no evidence for an effect on the risk of aSAH or related cerebrovascular events. These findings support haptoglobin as a potential treatment in aSAH to mitigate the neurotoxic effects of free haemoglobin and improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HaptoglobinsSubarachnoid HemorrhageHumansMendelian Randomization AnalysisMaleFemaleMiddle AgedPolymorphism, Single NucleotideAged

Substanzen

Haptoglobins

Autor:innen und Institutionen

  • CSL BEHRING L.L.C., King of Prussia, Pennsylvania, United States of America.
  • Lane Clark & Peacock LLP, London, United Kingdom.
  • CSL Innovation GmBH, Marburg, Germany.
  • MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

ORCID-Profile: Loukas Zagkos, Gregory Kato

Förderung

  • CSL Behring

Zitieren

APA

Kayode, G. A., Zagkos, L., Oboli, G., Abraham, S., Kato, G., Ataher, Q., Farmakioti, E., Tremmel, L., & Burgess, S. (2025). Cerebrospinal fluid haptoglobin levels and outcome after aneurysmal subarachnoid haemorrhage: Evidence from Mendelian randomization. PLOS One. https://doi.org/10.1371/journal.pone.0329287

Vancouver

Kayode GA, Zagkos L, Oboli G, Abraham S, Kato G, Ataher Q, et al. Cerebrospinal fluid haptoglobin levels and outcome after aneurysmal subarachnoid haemorrhage: Evidence from Mendelian randomization. PLOS One. 2025. doi:10.1371/journal.pone.0329287

BibTeX
@article{Kayode2025,
  author = {Kayode, Gbenga A and Zagkos, Loukas and Oboli, Godspower and Abraham, Sonya and Kato, Gregory and Ataher, Quazi and Farmakioti, Evangelia and Tremmel, Lothar and Burgess, Stephen},
  title = {Cerebrospinal fluid haptoglobin levels and outcome after aneurysmal subarachnoid haemorrhage: Evidence from Mendelian randomization},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0329287}
}
Kostenlos starten →